We have examined the combined effects of transforming growth factor-fl 8), serum and y-interferon (y-IFN) on collagen synthesis by fibroblasts and compared the response of fibroblast subpopulations to TGF-,6. Human diploid fibroblasts were treated with TGF-/J alone and with serum or y-IFN. Cells were labelled with radioactive amino acids, and collagen production was measured as collagenase-digestible radioactivity. Collagen mRNA was determined by a solution-hybridization assay using procollagen-al [1] cDNA clone HF 677. The results showed that either serum or TGF-,/ increased incorporation, collagen production and mRNA by fibroblasts approx. 2-fold; however, collagen synthesis relative to total protein synthesis and collagen mRNA relative to total polyadenylated [poly (A)'] RNA were not affected. Only serum activated cell growth. Collagen production increased approx. 4-fold in cells exposed to both TGF-,/ and serum, and this increase was equal to that expected for an additive effect by both components. Treatment with y-IFN decreased collagen production and collagen mRNA to 44 and 400 respectively, whereas total incorporation and poly(A)+ RNA were affected only marginally. Cells exposed simultaneously to both y-IFN and TGF-, produced less collagen and contained less mRNA than did those treated with TGF-, alone. The y-IFN decreased collagen synthesis in control and TGF-,/-treated cultures to a similar extent, and TGF-,/ increased collagen synthesis 2-fold in cells pre-treated with y-IFN. Fibroblast strains obtained in medium containing plasma-derived serum synthesized approximately half as much collagen as did cells derived from the same explant in the presence of fresh human serum, and TGF-,/ stimulated collagen production and mRNA in both cell strains. We conclude that TGF-fl, serum and y-IFN regulate collagen synthesis by independent mechanisms, and that the combined action of these components plays a s-ignificant role in regulating collagen synthesis during wound healing and tissue repair.
INTRODUCTION
Wound healing and tissue repair involve a complex series of biological events which include inflammation, cellular migration, fibroblast proliferation, production of collagen and tissue remodelling (Ross, 1968; Dvorak, 1986) . These events are influenced and regulated by the inflammatory response which followed immediately after tissue injury. A major component of inflammation is inflammatory cells, which infiltrate the damaged tissue to control invading micro-organisms and remove dead tissue. During this process, these cells are activated to secrete a variety of substances such as enzymes, growth factors and cytokines. Many of these substances affect the biological activities of fibroblasts and activate them to proliferate, migrate into the wound site and produce matrix constituents; once tissue integrity is restored, the numbers of fibroblasts and their synthetic activities return to normal values (Ross, 1968; Dvorak, 1986) . Two factors will significantly influence the manner in which fibroblasts respond to the growth factors and other mediators of inflammation. First, several substances are present at the site of injury and some of them may have opposing effects. For example, platelet-derived growth factor and serum promote fibroblast growth, whereas products of activated mononuclear cells inhibit the growth (Korotzer et al., 1982; Ross et al., 1986) . Serum, platelet-derived growth factor and TGF-/i stimulate fibroblasts to synthesize more collagen, whereas y-IFN and mononuclear-cell factors cause inhibition (Narayanan & Page, 1983 Rosenbloom et al., 1984; Narayanan et al., 1985; Wrana et al., 1986; Ignotz & Massague, 1986; Ignotz et al., 1987; Czaja et al., 1987) . Second, interactions between fibroblasts and regulatory molecules may be selective. Thus the Cl component of complement is mitogenic only to a subpopulation of fibroblasts, and prostaglandin E2 and products of mononuclear cells affect growth and synthesis in only some, not all, fibroblasts (Ko et al., 1977; Korotzer et al., 1980; Korn et al., 1984) . Therefore, the types and concentrations of these molecules, which vary at different stages of inflammation, are likely to determine the progression of events from inflammation to repair, and aberrations of this process could affect normal wound healing and result in pathological conditions such as atherosclerosis and fibrosis (Ross, 1986) . Because collagen synthesis is a major feature of wound healing, and fibrosis and TGF-fl may play a significant role in these processes (Sporn et al., 1983; Roberts et al., 1986; Lawrence et al., 1986; Mustoe et al., 1987) , we have studied how the stimulatory effect of TGF-fl on collagen synthesis is affected by other substances which stimulate or inhibit collagen synthesis. We have used serum and y-IFN respectively to mimic these effects (Ross, 1968; Rosenbloom et al., 1984; Narayanan & Page, 1987; Vol. 260 Abbreviations used: TGF-fl, transforming growth factor-,8; y-IFN, y-interferon; poly(A)+ RNA, polyadenylated RNA.
* To whom reprint requests should be addressed. Czaja et al., 1987) . In addition, we have also examined how TGF-, affects collagen production in two substrains of fibroblasts which were obtained from the same source but differ in growth rate, cell-surface receptors and capacity to produce collagen. The last case is particularly illustrative of healthy and diseased tissues which appear to contain different fibroblast subtypes that may not respond to regulatory molecules in the same manner (LeRoy, 1972; Hassell et al., 1976; Bordin et al., 1984; Korn, 1985 Fibroblasts were obtained from explants of human gingiva taken from individuals with clinically and radiographically healthy periodontal tissues. Cells were grown and maintained as described previously (Narayanan & Page, 1983) . Each experiment was done in triplicate and repeated at least three times. Cultures of subconfluent cell density (1.6 + I0' cells/cm2) were treated with the substances specified in Dulbecco-Vogt medium for 24 h. Before labelling, cells were preincubated for 1 h in serumfree medium without the mediators but containing 50,ug each of ascorbic acid and /-aminopropionitrile/ ml (Hassell et al., 1976; Ko et al., 1977) . They were then labelled for 3 h with L-[2,3,-3H]proline (sp. radioactivity 35.2 Ci/mmol) and [2-3H] glycine (sp. radioactivity 43.5 Ci/mmol) (each 10 Ci/ml) (Narayanan & Page, 1983 .
Measurement of incorporation and collagen production After labelling, medium was separated and cells were harvested in 0.5 M-NH1OH. Medium and cell proteins were pooled and proteins were precipitated with 10", (w/v) trichloroacetic acid containing 1 %o tannic acid.
The precipitate was washed and incorporation measured as described previously (Huey et al., 1980) . Collagen was quantified after digestion with purified bacterial collagenase (Huey et al., 1980) . RNA extraction and determination of mRNA Total fibroblast RNA was extracted by the guanidine isothiocyanate/CsCI gradient procedure of Chirgwin et al. (1979) . Procollagen mRNA was determined in terms of procollagen-ocl[I]mRNA by a solution-hybridization procedure described by Voss & Bornstein (1986) .
The RNA probe used was prepared by labelling proacl [I] clone HF 677, which was subcloned into pUC12 polylinker site downstream to a SP6 promotor, with 5'-_[o-[35S] thio]UTP (sp. radioactivity 1400 Ci/mmol) (Voss & Bornstein, 1986) . Proocl[I] RNA standard was from the same plasmid in which the cDNA was linked in the opposite orientation (Voss & Bornstein, 1986) .
Various concentrations of RNA from each culture, ranging from 0.25 to 2.0 #g, were hybridized with the probe at 68°C for 16 h, after which unhybridized material was digested with a mixture of RNAases A and T1. Then the RNA hybrid was precipitated with ice-cold 10 % trichloroacetic acid, filtered and counted for radioactivity (Narayanan et al., 1985; Voss & Bornstein, 1986; Narayanan & Page, 1987) . Poly(A)+ mRNA was determined similarly, except that hybridization was done for 3 h each at 65°C and then 37°C (Voss & Bornstein, 1986 * Increase in collagen production in the presence of I and 1000 serum relative to 000 serum was 1.4-and 1.7-fold respectively; 10" serum caused a 1.8-fold increase in collagen mRNA. Table 3 . Effect of TGF-I8 on collagen synthesis by human fibroblasts previously treated with y-IFN Cells were treated with y-IFN in serum-free medium for 24 h after which medium was removed and cells were washed. Fresh medium supplemented with the specified polypeptides was added, and the cells were incubated for a further 24 h. Collagen production and mRNA were then measured. Values for collagen are means + S.D. for triplicate samples. Values in paTentheses are means + S.D. for three separate experiments. Differences between these and the % increase obtained with TGF-,/ alone were not statistically significant (P > 0.4). 'Control' refers to cultures not treated with either y-IFN or TGF-fl. Table 4 . Effect of y-IFN on collagen production by human fibroblasts previously treated with TGF-/8
Cultures were treated with 40 pM-TGF-f for 24 h. Medium was then removed, cells were washed and fresh serum-free medium containing the substances specified was added. The incubation was continued for 24 h and then collagen production and mRNA were measured. Values for collagen are means + S.D. for triplicate samples. Values in parentheses represent means + S.D. for three separate experiments. The differences between TGF-f/y-IFN and control/y-IFN treatments were not statistically significant (P > 0.2 and > 0.5 for collagen production and mRNA respectively). The 'control' cultures were not subjected to the first TGF-f8 treatment. gingival explant under two growth conditions. One strain was obtained in medium containing 10 % fresh human serum (FS cells) and the other in medium with 100 heatinactivated plasma-derived serum (PS cells) (Bordin & Page, 1988) . These cell strains were selected because they exhibit heritable differences in growth rate and cellsurface characteristics (Bordin & Page, 1988) . The cells were exposed to TGF-,f and collagen production and mRNA levels were measured. Fig. 2 shows that the PS The fibroblasts were exposed to 40 pM-TGF-,/, after which collagen production (a) and mRNA (b) were measured as described in the Experimental section. In (a) means+ S. (Fig. 2a) . Collagen mRNA data were also consistent with these results (Fig. 2b ).
DISCUSSION
Our data on stimulation of collagen synthesis (measured in terms of collagen production and mRNA) by TGF-,? and serum, and inhibition by y-IFN, agree in general with those of others (Manner, 1971; Rosenbloom et al., 1984; Wrana et al., 1986; Ignotz & Massague, 1986; Czaja et al., 1987) .
The degree of stimulation by TGF-,/ is also comparable with that observed by others in human fibroblasts (Wrana et al., 1986; Raghow et al., 1987) . However, Wrana et al. (1986) reported only marginal stimulation in confluent cultures, whereas we observed that both confluent and subconfluent cultures responded equally well to TGF-,/ (2.0+0.3-fold, n = 3, and 2.0+0.3-fold, n = 4, respectively). Although serum and TGF-/J appear to stimulate synthesis ofall proteins, y-IFN inhibits collagen synthesis without significantly affecting total incorporation and poly(A)+ mRNA (Rosenbloom et al., 1984) . It is possible that the differences in production observed in our experiments arose because of changes in specific radioactivities of the amino acids in the precursor pool. In the treated cells differences in specific radioactivity of precursor amino acids can arise owing to (a) variations in the intracellular concentration of unlabelled amino acids that dilutes the radioactive precursor at the time of its addition, and (b) changes in the rates of cellular protein degradation, a process which continuously dilutes the radioactivity of intracellular pool throughout the period of measurement. The former possibility appears unlikely, because: (1) cells were preincubated in serum-free medium before labelling, to minimize differences in pool size; (2) the same results were obtained by increasing the concentration of the labels 4-fold, and thus their specific radioactivity (results not shown); (3) the effect of the three components persists for up to 24 h after removal from the medium; and (4) (1989) have observed that TGF-,f suppresses the expression of procollagenase while stimulating the tissueinhibitor of metalloproteinases and plasminogen activator-inhibitor. Serum, however, does not appear to affect collagen degradation significantly (Narayanan & Page, 1987 (Wrana et al., 1986; Raghow et al., 1987) is far less than the 10-20-fold observed by Penttinen et al. (1988 (Narayanan & Page, 1987) .
Our experiments were designed mainly to obtain information about how collagen synthesis by fibroblasts is affected when the cell is presented with more than one inflammatory mediator. The magnitude of stimulation of collagen synthesis by TGF-,6' is not affected by serum [collagen production increased 3.0 + 0.4 and 3.3 + 1.0-fold (n = 3) in the presence of 20 % and 1000% serum respectively]. In the presence of both components stimulation is roughly equal to the total obtained with each component alone (Table 1) . Similarly, stimulation by TGF-, was the same in cultures containing and previously treated with y-IFN (Tables 2 and 3 ). y-IFN inhibition was also the same in control and TGF-fltreated cultures (Tables 2 and 4 ). These data indicate that TGF-/3, serum and y-IFN are effective independently of each other. The rate of gene transcription is regulated by synergistic interactions of several factors such as cisacting DNA sequences (promoters and enhancers), and trans-acting protein factors. The enhancers appear to contain different elements for binding different regulatory substances, and the trans-acting factors interact with the DNA elements through mechanisms that involve cooperative binding or other protein-protein interactions (Khoury & Gruss, 1983; Sassone-Corsi & Borrelli, 1986) . The fact that TGF-fl, serum and y-IFN each can affect collagen synthesis independently of each other indicates that these components perhaps exert their action by different mechanisms, or by interacting with different regulatory sequences on the collagen gene. Similar differential regulation has been observed for the proto-oncogene c-fos by growth factors (Verma & Sassone-Corsi, 1987) . In collagen genes, enhancer DNA sequences are located in the first intron, and 274 bp-and 1106 bp-long sequences have been identified in human al [I] and mouse a2[I] collagen genes respectively (Rossouw et al., 1987; Bornstein et al., 1987; Rossi & de Crombrugghe, 1987) . However, TGF-,/ and serum effects are not specific, so therefore their action is likely to involve common mechanisms which affect the expression of collagen as well as other genes. Persistence of their effect even after 24 h after their removal indicates that their mechanism of action may involve synthesis of molecules, perhaps nuclear proteins, that serve as mediators. This possibility is supported by the observation that cycloheximide, an inhibitor of protein synthesis, abrogated the TGF-,? stimulation of collagen mRNA production (Penttinen et al., 1988) .
Our results indicate that the combined stimulation of collagen synthesis by TGF-/3, serum and other substances can be beneficial during wound healing and tissue repair when the matrix must be reconstituted rapidly. On the other hand, the ability of y-IFN (and other molecules) to inhibit collagen synthesis, even in the presence of TGF-,/, will help to control excess production when tissue repair is complete or near completion (Ross, 1968 (Ross, , 1986 Dvorak, 1986 (LeRoy, 1972; Hassell et al., 1976; Narayanan et al., 1988) .
